Join
Live feed
·
PRReleasevia Quantisnow
FibroGen Inc logo

FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
FGEN· FibroGen Inc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FGEN (FibroGen Inc) and more on Quantisnow.